drugset / Trial / NCT00834275
Cefadroxil 500 mg Capsules Under Fasting Conditions
RandomizedCrossoverOpen-labelOther
Summary
The objective of this study is to compare the relative bioavailability of cefadroxil 500 mg capsules (manufactured by Teva Pharmaceuticals USA) with that of DURICEF® 500 mg capsules (manufactured by Bristol-Myers Squibb Company) when dosed (1 x 500 mg capsules) in normal healthy non-smoking male and female subjects under fasting conditions.
Timeline
- Start
- 2004-09
- Primary completion
- 2004-10
- Completion
- 2004-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cefadroxil | Small molecule | 500 mg | — |
Indications
No indication recorded.